These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19439746)

  • 1. Images in clinical medicine. Extravasation of epirubicin.
    Vano-Galvan S; Jaen P
    N Engl J Med; 2009 May; 360(20):2117. PubMed ID: 19439746
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of epirubicin-induced cardiomyopathy in familial cardiomyopathy.
    Shipman KE; Arnold I
    J Clin Oncol; 2011 Jun; 29(18):e537-8. PubMed ID: 21482996
    [No Abstract]   [Full Text] [Related]  

  • 3. Images in emergency medicine. Swollen hand. Anthracycline chemotherapy extravasation.
    Schulmeister L; Pollack CV
    Ann Emerg Med; 2011 Apr; 57(4):417, 422. PubMed ID: 21453822
    [No Abstract]   [Full Text] [Related]  

  • 4. Accidental anthracycline extravasation.
    Held-Warmkessel J
    Nursing; 2007 Dec; 37(12 Pt.1):72. PubMed ID: 18090648
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
    Takatsuka Y; Shin E; Fukuda K; Mishima H; Tono T; Yagyuu T; Kobayashi K; Kikkawa N
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1546-8. PubMed ID: 7574755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin for breast cancer may cause considerable venous sclerosis.
    Bolton-Maggs P; Flavin A
    BMJ; 2005 Oct; 331(7520):816. PubMed ID: 16155047
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].
    Shen ZZ; Liu GY; Su FX; He PQ; Yang MT; Shi JY; Sheng Y; Zou Q; Li YF
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):126-8. PubMed ID: 15946557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer.
    Conte PF; Michelotti A; Baldini E; Salvadori B; Gennari A; Da Prato M; Tibaldi C; Salzano E; Gentile A
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):28-31. PubMed ID: 8893896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of tolerance and toxicity of CEF-100 regimen versus CEF-60 regimen as adjuvant therapy for breast cancer].
    Hui R; Zhang M; Hao XM; Zhang J
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):871-4. PubMed ID: 18396651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for breast cancer during pregnancy.
    Mathelin C; Annane K; Dufour P; Liegeois P; Bergerat JP
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):260-2. PubMed ID: 16024158
    [No Abstract]   [Full Text] [Related]  

  • 11. An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.
    Prado CM; Lima IS; Baracos VE; Bies RR; McCargar LJ; Reiman T; Mackey JR; Kuzma M; Damaraju VL; Sawyer MB
    Cancer Chemother Pharmacol; 2011 Jan; 67(1):93-101. PubMed ID: 20204364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative-pressure wound therapy and early pedicle flap reconstruction of the chest wall after epirubicin extravasation.
    Papadakis M; Rahmanian-Schwarz A; Bednarek M; Arafkas M; Holschneider P; Hübner G
    J Vasc Access; 2017 May; 18(3):e27-e29. PubMed ID: 28165571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
    Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
    J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of locally advanced breast cancer successfully treated with intra-arterial infusion chemotherapy of high-dose epirubicin].
    Kim Y; Takatsuka Y; Hasegawa S; Kondou M; Hirao T; Kan K; Fukunaga M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2119-22. PubMed ID: 9838916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response evaluation with mammography and ultrasound].
    Junkermann H; Schmid H; Sinn HP; Wallwiener D
    Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
    [No Abstract]   [Full Text] [Related]  

  • 17. [A clinical trial of neoadjuvant intraarterial chemotherapy for the treatment of locally advanced breast cancer].
    Takatsuka Y; Shin E; Kikkawa N
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1523-5. PubMed ID: 8854796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of activated charcoal-epirubicin suspension for treatment of breast cancer with axillary metastasis].
    Wu WJ; Zeng J; Pan CE
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1812-4. PubMed ID: 17259127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recall phenomenon following epirubicin.
    Wilson J; Carder P; Gooi J; Nishikawa H
    Clin Oncol (R Coll Radiol); 1999; 11(6):424-5. PubMed ID: 10663338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma.
    Beresford M; Lyburn I; Sanghera B; Makris A; Wong WL
    Breast J; 2007; 13(4):424-5. PubMed ID: 17593051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.